NASDAQ: ACSTAcasti Pharma Inc Stock Ownership - Who owns Acasti Pharma?
Insider buying vs selling
Have Acasti Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Donald Olds | Director | 2023-08-31 | 381 | $2.05 | $781.05Buy |
ACST insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ACST insiders and whales buy or sell their stock.
ACST Shareholders
What type of owners hold Acasti Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Grace 2018 Irrevocable Trust Rajitha | 62.96% | 4,689,547 | $8.30M | Insider |
| George Kottayil | 39.85% | 2,968,186 | $5.25M | Insider |
| Vimal Kavuru | 10.02% | 746,064 | $1.32M | Insider |
| William A. Haseltine | 4.47% | 332,836 | $589.12k | Insider |
| Prashant Kohli | 1.72% | 128,138 | $226.80k | Insider |
| John Canan | 1.34% | 100,000 | $177.00k | Insider |
| Renaissance Technologies LLC | 0.91% | 67,600 | $119.65k | Institution |
| Amresh Kumar | 0.90% | 66,712 | $118.08k | Insider |
| Janelle Dalvise | 0.70% | 52,500 | $92.93k | Insider |
| Donald Olds | 0.53% | 39,173 | $69.34k | Insider |
ACST vs Biotech Stocks
Acasti Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.